Medline Inc. (MDLN)
| Market Cap | 57.58B |
| Revenue (ttm) | 28.43B +11.5% |
| Net Income | 1.16B -3.4% |
| EPS | 1.43 +1,982.8% |
| Shares Out | 1.31B |
| PE Ratio | 30.63 |
| Forward PE | 29.79 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,830,964 |
| Open | 43.00 |
| Previous Close | 44.05 |
| Day's Range | 42.90 - 44.53 |
| 52-Week Range | 34.89 - 50.88 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 49.91 (+13.87%) |
| Earnings Date | Feb 25, 2026 |
About MDLN
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam g... [Read more]
Financial Performance
In 2025, Medline's revenue was $28.43 billion, an increase of 11.47% compared to the previous year's $25.51 billion. Earnings were $1.16 billion, a decrease of -3.42%.
Financial StatementsAnalyst Summary
According to 23 analysts, the average rating for MDLN stock is "Strong Buy." The 12-month stock price target is $49.91, which is an increase of 13.87% from the latest price.
News
Medline Inc. announces pricing of secondary offering of class A common stock
NORTHFIELD, Ill., March 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of a previously announced secondary offering of 75,000,000 shares of Medline In...
Medline Inc. announces launch of secondary offering of Class A common stock
NORTHFIELD, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., ...
Medline Analysts Boost Their Forecasts Following Q4 Results
Medline Inc (NASDAQ: MDLN) reported mixed results for the fourth quarter on Wednesday.
Medline Inc. (MDLN) Q4 2025 Earnings Call Transcript
Medline Inc. (MDLN) Q4 2025 Earnings Call Transcript
Medline Reports Fourth Quarter and Full Year 2025 Results
NORTHFIELD, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions ...
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference
NORTHFIELD, Ill., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are sched...
Medline to report fourth quarter and full year 2025 results on February 25, 2026
NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, Fe...
Medline Industries: Solid Physical Moat With Visible Earnings Growth Runway
Medline Industries (MDLN) earns a buy rating due to its robust vertically integrated model and scale-driven logistics advantages. MDLN's private label strategy enables margin expansion as contract win...
Medline Inc. (MDLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medline Inc. (MDLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Analysts Say Medline Has The Secret Sauce For Sustained Growth
Several analysts initiated coverage on Medline Inc. (NASDAQ: MDLN) on Monday, one of the largest providers of medical-surgical products and supply chain solutions.
Analysts initiate Medline with bullish ratings after blockbuster IPO
Brokerages began coverage of Medline with largely bullish ratings on Monday, betting on supply chain strength and brand penetration, following the firm's upsized U.S. initial public offering in Decemb...
Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference
NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are sched...
U.S. IPO Weekly Recap: Medline Headlined Final Week Before Christmas
Two sizable IPOs priced this week, joined by seven SPACs. Ten IPOs and eight SPACs submitted initial filings. No IPOs are currently scheduled in the week ahead, although smaller issuers may join the c...
The Score: Medline, Tesla, Warner, Trump Media and More Stocks That Defined the Week
Here are some of the major companies whose stocks moved on the week's news.
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
NORTHFIELD, Ill., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized initial public offering of 248,439,654 shares of its Class A ...
Medline IPO: Record-Breaking $6.26 Billion Offering And What It Means For Investors
Medline Inc. completed a record-setting $6.26B IPO, allocating proceeds primarily to reduce leveraged buyout debt from 2021. MDLN operates globally with $20.6B YTD revenue, stable 10% growth, and robu...
Trump defends economy, CPI report returns, monster Medline IPO, and more in Morning Squawk
President Donald Trump defended the U.S. economy and blamed his predecessor. "I inherited a mess," he said.
Medline - A Little Too Healthy Demand For Its Offering
Medline completed a highly successful IPO, now trading at a $83 billion valuation, being granted a demanding 39x earnings multiple. Medline generates $25.5 billion in annual revenue, up 10% year-over-...
Medline's IPO was the largest we've seen in over four years, says Jim Cramer
'Mad Money' host Jim Cramer breaks down Medline's IPO.
Medline stock is a little too expensive to buy post IPO, Jim Cramer says
CNBC's Jim Cramer reviewed Medline, a medical supplies giant that made its market debut Wednesday. He said he'd wait for a pullback to buy the stock after shares soared more than 41%.
Medline's IPO underscores broad investor appetite for a sleepy corner of the healthcare business
Medline's stock soared more than 40% above its IPO price on Wednesday, its first day of trading.
Medline shares surge 30% — worth $46B in Wall Street's biggest IPO of the year
Northfield, Illinois-based Medline, founded in 1966, is a key manufacturer and distributor of medical supplies such as surgical kits, gloves and gowns used by hospitals worldwide.
Boring companies are going public again, strong signal for 2026 IPOs: Axios' Primack
CNBC's "The Exchange" team discusses the IPO market, Medline's trading debut and more with Dan Primack, business editor at Axios.
Medline opens at $35 per share in Nasdaq debut, above IPO price of $29
Shares of U.S. medical supplies giant Medline jumped in its Nasdaq trading debut, marking the biggest IPO of the 2025 globally. CNBC's Leslie Picker has the details.
Medline opens at $35, above IPO price of $29
CNBC's Leslie Picker reports on shares of U.S. medical supplies giant Medline jumping in its Nasdaq trading debut, marking the biggest IPO of the 2025 globally.